Company Overview of ISTA Pharmaceuticals Inc.
ISTA Pharmaceuticals, Inc., a commercial-stage, multi-specialty pharmaceutical company, discovers, develops, and markets remedies for diseases and conditions of the eye in the United States. It offers products to treat allergy and serious disease of the eye; and therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. The company’s marketed products comprise BROMDAY, a bromfenac ophthalmic solution for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions; BEPREVE, a bepotastine besilate ophthalmic solution for ocular itching associated with allergic conjunctivitis; ISTALOL, a timolol...
50 Technology Drive
Irvine, CA 92618
Founded in 1992
Key Executives for ISTA Pharmaceuticals Inc.
Chief Financial Officer and Vice President of Corporate Development
Vice President of Operations
Chief Accounting Officer and Vice President of Finance
Compensation as of Fiscal Year 2014.
ISTA Pharmaceuticals Inc. Key Developments
Bausch + Lomb Announces Settlement with the U.S. Department of Justice to Resolve and Conclude ISTA Pharmaceuticals Inc
May 24 13
Bausch + Lomb announced has reached agreement with the U.S. government to resolve and conclude civil and criminal allegations against ISTA Pharmaceuticals Inc. The settlement involves conduct by ISTA that occurred between January 2006 and March 2011, well before Bausch + Lomb's acquisition. Bausch + Lomb was aware of the government investigation prior to its acquisition, and has fully cooperated with the government to resolve this matter. As part of the settlement, ISTA has agreed to pay approximately $34 million in civil and criminal fines including interest and attorney's fees, and will be prohibited from participating in federal healthcare programs such as Medicare and Medicaid. However, Bepreve(R), Bromday(R), Istalol(R), Prolensa(R) and Vitrase(R) have been transferred to Bausch & Lomb Incorporated, and therefore are not subject to any exclusion resulting from this settlement and continue to be eligible for reimbursement under those programs.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries